Home NDC 21695-399 Zyvox
Product NDC 21695-399
11-digit product format 216950399
Labeler code 21695
Product ID 21695-399_50630775-7f76-413e-9278-ba298dd7f187
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name linezolid
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Rebel Distributors Corp
Application NDA021130
Marketing category NDA
Marketing start 2000-04-18
Marketing end 0000-00-00
Substance LINEZOLID
Active strength 600 mg/1
Pharmacologic classes Oxazolidinone Antibacterial [EPC],Oxazolidinones [CS]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 21695-399-20 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 21695-399-20 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 21695-399-20 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 21695-399-20 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 21695-399-20 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 21695-399-20 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 21695-399-20 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 21695-399-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 21695-399-20 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 21695-399-20 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 21695-399-20 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 21695-399-20 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 21695-399-20 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 21695-399-20 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 21695-399-20 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 21695-399-20 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 21695-399-20 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 21695-399-20 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 21695-399-20 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 21695-399-20 e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 21695-399-20 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 21695-399-20 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021130-001 ZYVOX LINEZOLID 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 N021130-002 ZYVOX LINEZOLID 600MG TABLET / ORAL RLD 2000-04-18
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021130-002 ZYVOX 600MG TABLET / ORAL RLD 2000-04-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021130-002 ZYVOX 600MG TABLET / ORAL RLD 2000-04-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET / ORAL RLD 2000-04-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET / ORAL RLD 2000-04-18 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 782e0a99824c…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 2 · 72 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021130-001 6559305 2021-01-29 Drug substance 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-001 6514529 2021-03-15 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-001 6559305*PED 2021-07-29 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-001 6514529*PED 2021-09-15 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-002 6559305 2021-01-29 Drug substance 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-002 6514529 2021-03-15 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-002 6559305*PED 2021-07-29 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-002 6514529*PED 2021-09-15 Pediatric extension 74a2ff9319b5…2021-12-28 21:50 UTC 2021-12 N021130-001 6559305 2021-01-29 Drug substance 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-001 6514529 2021-03-15 Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-001 6559305*PED 2021-07-29 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-001 6514529*PED 2021-09-15 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-002 6559305 2021-01-29 Drug substance 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-002 6514529 2021-03-15 Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-002 6559305*PED 2021-07-29 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-002 6514529*PED 2021-09-15 Pediatric extension 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-001 6559305 2021-01-29 Drug substance 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-001 6514529 2021-03-15 Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-001 6559305*PED 2021-07-29 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-001 6514529*PED 2021-09-15 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-002 6559305 2021-01-29 Drug substance 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-002 6514529 2021-03-15 Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-002 6559305*PED 2021-07-29 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-002 6514529*PED 2021-09-15 Pediatric extension 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021130-001 6559305 2021-01-29 Drug substance 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-001 6514529 2021-03-15 Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-001 6559305*PED 2021-07-29 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-001 6514529*PED 2021-09-15 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-002 6559305 2021-01-29 Drug substance 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-002 6514529 2021-03-15 Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-002 6559305*PED 2021-07-29 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-002 6514529*PED 2021-09-15 Pediatric extension 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021130-001 6559305 2021-01-29 Drug substance 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-001 6514529 2021-03-15 Drug product 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-001 6559305*PED 2021-07-29 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-001 6514529*PED 2021-09-15 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-002 6559305 2021-01-29 Drug substance 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-002 6514529 2021-03-15 Drug product 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-002 6559305*PED 2021-07-29 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-002 6514529*PED 2021-09-15 Pediatric extension 8869cabd3fbd…
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 21695-399-20 Zyvox 20 in 1 BOTTLE TABLET, FILM COATED 20 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded linezolid ACTIVE INGREDIENT ISQ9I6J12J ZYVOX (LINEZOLID) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP] 1 linezolid ACTIVE MOIETY ISQ9I6J12J ZYVOX (LINEZOLID) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP] 1 carnauba wax INACTIVE INGREDIENT R12CBM0EIZ ZYVOX (LINEZOLID) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP] 1 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U ZYVOX (LINEZOLID) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP] 1 hydroxypropyl cellulose INACTIVE INGREDIENT RFW2ET671P ZYVOX (LINEZOLID) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP] 1 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ZYVOX (LINEZOLID) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP] 1 magnesium stearate INACTIVE INGREDIENT 70097M6I30 ZYVOX (LINEZOLID) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP] 1 polyethylene glycol INACTIVE INGREDIENT 3WJQ0SDW1A ZYVOX (LINEZOLID) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP] 1 starch, corn INACTIVE INGREDIENT O8232NY3SJ ZYVOX (LINEZOLID) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP] 1 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP ZYVOX (LINEZOLID) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 21695-399 ZYVOX (LINEZOLID) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP] 1 Legacy NDC, 1 package rows 20110127_50630775-7f76-413e-9278-ba298dd7f187.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 21695-399-20 21695039920 20 in 1 BOTTLE Historical